Table 3 Comparison of HRV detection between patients with or without ICS treatment
|  | All (n = 54) | Non-ICS group (n = 26) | ICS group (n = 28) | p-value |
|---|---|---|---|---|
| Â | n (%) | n (%) | n (%) | Â |
Viral pathogen detected | 45 (83.3%) | 23 (88.5%) | 22 (78.6%) | 0.47 |
    HRV | 33 (61.1%) | 21 (80.8%) | 12 (42.9%) | 0.004* |
        HRV-A | 16 (29.6%) | 9 (34.6%) | 7 (25.0%) | 0.44 |
        HRV-B | 1 (1.9%) | 0 (0.0%) | 1 (3.6%) | 1.00 |
        HRV-C | 16 (29.6%) | 12 (46.2%) | 4 (14.3%) | 0.01* |